No doubt, the turbocharging of IP is in the assay matrices of production and potency. It's what separates MSB from Jacko pumping out stem cells churned out of a yoghurt maker in Manila and injecting them into eyeballs and spines for $10k a pop.
For a cell with a complex profile of powerful cascaded MOAs that move beyond the reductio ad absurdum pretence of single action drugs, assay matrices ARE the science behind a marketable product - for trial success, and potency guarantee for national approvals.
No doubt, the turbocharging of IP is in the assay matrices of...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.015(1.40%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.12 | $1.08 | $11.51M | 10.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17804 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 230637 | 5 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.015 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.12 | $1.08 | 1937390 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| MSB (ASX) Chart |